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Dans cette étude, nous avons recherché la cause génétique du syndrome d’automutilation chez les 
chiens de chasse, qui correspond chez l’Homme à une neuropathie sensitive de type HSAN. Nous 
avons identifié une mutation en amont d’un gène codant un facteur neurotrophique : GDNF (« Glial 
cell line-Derived Neurotrophic Factor »). Cette mutation ségrége parfaitement avec la maladie chez 
250 chiens de chasse de statut clinique connu et est absente chez 900 chiens indemnes de 130 autres 
races. Cette mutation étant située dans un ARN long non codant, une analyse fine de la région chro-
mosomique et des études d’expression de gènes ont été réalisées pour comprendre son rôle dans la 
physiopathologie de la maladie. Ainsi, non seulement, nous apportons un nouveau gène candidat 
pour les neuropathies humaines, mais nous proposons également un mécanisme de régulation trans-
criptionnelle original, basé sur un « partenariat » entre le gène codant le facteur neurotrophique et 
l’ARN long non codant. 
Mots-clés : neuropathies sensorielles, HSAN, douleur, modèle chien, génétique, éléments régulateurs.
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In this study, we sought the genetic cause of self-mutilation syndrome in sporting dogs, which cor-
responds to human Hereditary Sensory and Autonomic Neuropathies (HSAN). We have identified a 
genetic mutation upstream of the gene encoding Glial cell line-Derived Neurotrophic Factor (GDNF). 
This mutation is responsible for insensitivity to pain in four sporting dog breeds and it perfectly seg-
regates with the disease in 250 sporting dogs of known clinical status. Moreover, it was not found in 
any of the 900 unaffected dogs from 130 different breeds. Since this mutation is localized in a long 
non-coding RNA, we performed an in-depth analysis of the genomic region (locus) as well as gene 
expression analyses to understand its role in the pathophysiology of the disease. Thus, in addition to 
the discovery of a novel candidate gene for HSAN in humans, we propose a transcriptional regulation 
mechanism based on a “partnership” between GDNF and a long non-coding RNA (lncRNA).
Key words: sensory neuropathy, HSAN, pain, dog model, genetics, ncRNA.
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INTRODUCTION
Human inherited peripheral neuropathies, including Charcot-
Marie-Tooth diseases (CMT) and hereditary sensory and auto-
nomic neuropathies (HSANs), are neurodegenerative diseases 
(Jerath & Shy, 2015). The main symptom is a progressive 
degeneration of sensory and autonomic neurons, causing insen-
sitivity to pain and temperature in feet and hands, sometimes 
leading to ulcerative mutilations (Indo, 2014). To date, 12 genes 
have been associated with human HSANs, however they only 
explain one third of affected patients. Therefore, spontaneous 
models of these diseases are needed to find new implicated 
genes. Interestingly, due to breeding practices, some dog breeds 
have spontaneously developed such diseases with high frequen-
cies (Granger, 2011). Four sporting breeds (German Short-
haired Pointers (GP), English Pointers (EP), English Springer 
Spaniel (ESS) and French Spaniel (FS)) are affected with diseases 
manifesting symptoms comparable to human HSANs (Paradis 
et al. 2005). In the affected dogs, the hallmarks of the disease 
are loss of pain sensation and feet ulceration, with the age of 
disease onset around four months old. Symptoms lead, in the 
majority of cases, to severe self-mutilations of the feet including 
claw loss, painless fractures, and digit amputations (figure 1). In 
this study, a large pedigree of French spaniels was first drafted; 
careful analysis of this pedigree revealed a recessive autosomal 
mode of inheritance, as previously described (Paradis et al. 
2005). A genetic association study has been performed and 
revealed a locus that was highly associated with the disease, on 
canine chromosome 4. Re-sequencing of the locus led to the 
identification of a strongly associated variant within the regula-
tory region of GDNF (Glial cell line-Derived Neurotrophic Factor), 
a neutrotrophic factor. 
MATERIALS AND METHODS
Ethics statement and sample collection
The work with dog samples was approved by the CNRS ethical 
board, France for UMR6290. The biological samples were 
obtained from the ‘Cani-DNA CRB’, (http://dog-genetics.
genouest.org) from veterinarians in the course of the dog fol-
low-up and the dog owners consented to the use of data for 
research purposes anonymously. 
 Nucleic acid extraction
Genomic DNA was extracted from EDTA blood samples, using 
the NucleoSpin® Blood L kit (Macherey-Nagel). RNA was 
extracted from Dorsal Root Ganglia (L6 and L7), using the 
NucleoSpin® RNA kit (Macherey-Nagel). 
 Genome-Wide Association Study (GWAS), 
locus sequencing by Next-Generation 
Sequencing (NGS) and Allele-Specific PCR
Using the Illumina Canine HD 173k (BeadChip), 62 dogs were 
genotyped at the Centre National de Génotypage (CNG; Evry, 
France) and statistical analyses were performed using Plink sof-
tware (v1.06-1.07) and GEMMA software (v0.94.1) (Purcell et al. 
2007; Zhou & Stephens, 2014). Locus sequencing was performed 
by capture-sequencing on four affected and four unaffected dogs 
by Integragen (Evry, France): the genomic libraries were made 
using the Illumina paired-end library sample preparation kit 
(Illumina Inc.), the capture experiment was performed with the 
Agilent SureSelect Target Enrichment System Kit and samples 
were paired-end sequenced on an Illumina HiSeq2000. Variants 
were identified using GATK software (McKenna et al, 2010) 
and candidate variants were genotyped on DNA from 400 dogs 
from 100 breeds, using an Allele Specific PCR method (AS-PCR) 
(Integragen).
Gene expression analysis
Reverse transcription was done on total RNA using the High-
capacity cDNA Reverse Transcription kit (Thermo Fisher 
Scientific). Pre-amplification was performed on cDNA with the 
TaqMan PreAmp Master Mix Kit (Thermo Fisher Scientific). 
qRT-PCR was performed on diluted pre-amplified cDNA with 
the TaqMan PCR master mix (Thermo Fisher Scientific) on 
the 7900HT Fast Real-Time PCR System (Applied Biosystems) 
using standard procedures. Each qRT-PCR was carried out 
in triplicate using pre-designed primers of GDNF (Thermo 
Fisher Scientific Reference: Cf03986046_g1), WDR70 (TFS 
Ref: Cf02651565_m1), NUP155 (TFS Ref: Cf02644933_m1) 
and SLC1A3 (TFS Ref: Cf02702629_m1). We also specifically 
designed other probes for GDNF-AS as well as the canine PPIB 
(Peptidylprolyl Isomerase B) gene for reference (Thermo Fisher 
Scientific). Relative amounts of the transcripts were determined 
using the standard procedures of the ∆∆Ct method.
RESULTS
Identification of the mutation
We focused the genetic analysis on the French Spaniel breed, 
using the DNA of 173 dogs with pedigree and clinical infor-
mation. The affected dogs presented severe self-mutilations 
with insensitivity to pain in the feet (figure 1). A genome-wide 
association study (GWAS) with 49 French Spaniels (21 affected 
and 28 unaffected dogs) led to the identification of a 3 Mb locus 
on canine chromosome 4 (CFA4) strongly associated with the 
disease (figure 2). Whole genome genotyping was then perfor-
med on dogs from the three other affected breeds, revealing a 
common homozygous haplotype, allowing us to narrow down 
the critical interval to 1.8 Mb.
Targeted re-sequencing of this locus of interest was performed 
on four affected and four unaffected sporting dogs. After quality 
controls and filtering of known canine polymorphisms (SNPs), 
156 variants remained. Using Allele Specific-PCR (AS-PCR), 
only one SNP perfectly segregated with the disease. Using Sanger 
sequencing in 250 sporting dogs of known clinical status, we 
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observed that the alleles of this SNP followed 
the expected transmission mode. In addition, the 
mutated allele was absent among 900 unaffected 
dogs from 130 different breeds.
Genomic analyses 
The variant (chr4.g.70,875,561C>T) is located in 
an intergenic region, 90 kb upstream of GDNF, 
known to be involved in the regulation of sensory 
neuron (Buj-Bello et al. 1995). Using an “in-house” 
improved annotation of the CanFam 3 genome 
assembly, the presence of a long non-coding RNA 
(lncRNA) was detected in the vicinity of GDNF 
(Wucher et al. 2017). Interestingly, the variant is 
located in the last exon of this lncRNA, potentially 
regulating GDNF.
Expression analyses by qRT-PCR
To test our hypothesis that the variant affects the 
expression of GDNF, and thus better understand 
its effect on the disease, we measured expression 
levels of both GDNF and the lncRNA. As GDNF 
is known to be expressed in Dorsal Root Ganglia 
(DRG) (Molliver et al. 1997), we measured the 
expression levels of GDNF and the lncRNA in 
DRG. Quantitative real-time PCR revealed that 
the levels of GDNF mRNA and lncRNA expression 
were both significantly decreased in affected dogs 
(60% and 80% respectively, p<0.0001). We also 
showed that the expression levels of the other genes 
located in the locus were not altered (figure 3), 
indicating that the mutation impacts only GDNF 
and the lncRNA. Thus we demonstrated that 
GDNF and its lncRNA have a correlated expres-
sion that is affected by the mutation.
DISCUSSION
The long-term collaboration between our research 
team and veterinarians involved in genetic diseases 
allowed the identification of a mutation responsible 
for self-mutilation in sporting dogs and introduces 
a new candidate gene for human sensory neuropa-
thies. The project focused on dogs with self-mutila-
tions as determined by a precise clinical question-
naire and allowed us to detect that all dogs with 
self-mutilations also presented insensitivity to pain, 
a symptom not always reported by the owners. We 
identified additional dogs presenting the “affected” 
homozygous haplotype, but without self-mutila-
tion. Indeed, their insensitivity to pain was not 
primarily detected, but the owners reported an 
abnormal gait. This observation reflects the dif-
ficulty in diagnosing such neuropathies in dogs, 
Figure 1 : Ulceration and fibrosis on a podale end of a dog affected with sensory neuropathy. 
Photos by Éric Guaguere. 
Figure 3 : qRT-PCR results in Dorsal Root Ganglia using the ∆∆Ct methodology (cases in grey, 
controls in white). PPIB gene was used as a control and levels of all genes and lncRNA were tested 
5 times with 3 replicates for each (t-test: p-value *<0.0001). The lncRNA, GDNF (denoted as 
NF gene), and their neighboring genes (WDR70, NUP155 and SLC1A3 noted Gene 1, Gene 
2 and Gene 3 respectively) are ordered as in the canine genome (CanFam3 assembly).
Figure 2 : (A) Manhattan plot of -log10 of p-values by chromosome. We identified a strong 
signal on chromosome 4 with Bonferroni corrected p-values ≤ 10-5. (B) Manhattan plot of -log10 
empirical p-values (EMP) obtained by permutations test confirmed the signal on chromosome 4 
(Permutation=100,000).
DOI : 10.4267/2042/61953
192
Bull. Acad. Vét. France — 2016 - Tome 169 - N°3  http://www.academie-veterinaire-defrance.org
 NOTES
presenting symptoms from insensitivity to pain to self-mutilation. 
This situation contributed to the spreading of this severe disor-
der in the four related sporting breeds (Paradis et al. 2005). This 
feature led us to consider self-mutilation, probably triggered by 
small fractures of toes or other injuries, as a consequence of the 
insensitivity to pain.
We collected DRG samples since DRG neurons and peripheral 
nerves were previously shown to be altered in affected dogs 
(Cummings et al. 1983). The qRT-PCR analysis of canine DRG 
led to the important finding that the mutation seems to affect 
a regulatory element of GDNF. Indeed, while the mutation is 
located in the last exon of the lncRNA, the expression levels of 
both GDNF and the lncRNA are decreased in affected dogs com-
pared to unaffected dogs (figure 3). Thus, the mutation impacts 
the fine-tuning of GDNF and its lncRNA expression levels. Our 
data support the implication of GDNF in the disease, and suggest 
that insufficient levels of this factor in the peripheral nervous 
system could prevent the growth and maintenance of the sensory 
neurons in the paws of affected puppies.
CONCLUSION
We identified the mutation responsible for a sensory neuropathy 
in sporting dogs, located in the last exon of a lncRNA and 
upstream of the neurotrophic factor GDNF. We showed that 
the lncRNA is co-regulated with GDNF and that the mutation 
dramatically diminishes both the expression of GDNF and the 
lncRNA. We anticipate that the disease is due to a decrease of 
GDNF mRNA expression, preventing the correct growth and 
maintenance of the small nerve fibers of the paws. To fully 
demonstrate this, we aim to perform electron microscopy on 
the sensory neurons of affected dogs. The identification of this 
mutation has led to the development of a genetic test useful 
for diagnosis and breeding to decrease disease frequency in 
predisposed breeds. 
In addition, GDNF is a relevant candidate for human HSAN and 
in pain mechanisms generally. We are therefore screening this 
candidate gene in affected human patients since only one third 
of HSAN patients are explained by known mutations. 
Our work illustrates the power of the canine model in genetics 
and also reveals the importance of exploring regulatory elements 
proximal to coding genes in human and dog diseases. Searching 
for the genetic causes of other neuropathies in dog breeds mani-
festing high incidence, has the potential to uncover novel genes 
important for both human and canine medicine. 
A more detailed description and analysis of the cellular impact of 
the mutation herein described is published in Plassais et al. 2016.
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